Gajilan, who has worked at Reuters for more than 14 years and was then digital news director, had been reading about artificial intelligence and custom GPTs—tailored AI models that users could ...

The open-source AI model improves transparency in predicting how proteins interact with other molecules, which could speed up drug discovery.